These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 1679571)

  • 61. [The healing of the bone erosions during therapy with gold preparations and D-penicillamine in rheumatoid arthritis patients].
    Kanevskaia MZ; Krel' AA; Slobodina GA; Chichasova NV; Semenova OIu
    Ter Arkh; 1990; 62(5):36-8. PubMed ID: 2396215
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Gold--by mouth?
    Symmons D
    J Clin Pharm Ther; 1989 Aug; 14(4):243-5. PubMed ID: 2571615
    [No Abstract]   [Full Text] [Related]  

  • 63. Elevated antigalactosyl antibody titers reflect renal injury after gold or D-penicillamine in rheumatoid arthritis.
    Malaise MG; Davin JC; Mahieu PR; Franchimont P
    Clin Immunol Immunopathol; 1986 Aug; 40(2):356-64. PubMed ID: 2941196
    [TBL] [Abstract][Full Text] [Related]  

  • 64. HLA antigens and toxic reactions to sodium aurothiopropanol sulphonate and D-penicillamine in patients with rheumatoid arthritis.
    Perrier P; Raffoux C; Thomas P; Tamisier JN; Busson M; Gaucher A; Streiff F
    Ann Rheum Dis; 1985 Sep; 44(9):621-4. PubMed ID: 3876081
    [TBL] [Abstract][Full Text] [Related]  

  • 65. [Rheumatoid factors during controlled krizanol treatment of rheumatoid arthritis patients].
    Alekberova ZS; Trofimova TM; Speranskiĭ AI; Beresten' TI
    Revmatologiia (Mosk); 1985; (3):19-22. PubMed ID: 3903922
    [No Abstract]   [Full Text] [Related]  

  • 66. [Case of drug (krizanol) hepatitis].
    Korneĭchuk AV; Kushnir LV
    Vrach Delo; 1982 Feb; (2):41-2. PubMed ID: 7064450
    [No Abstract]   [Full Text] [Related]  

  • 67. Nephrotoxic effect of parenteral and intraarticular gold. Ultrastructure and electron microprobe examination of clinical and experimental material.
    Yarom R; Stein H; Peters PD; Slavin S; Hall TA
    Arch Pathol; 1975 Jan; 99(1):36-42. PubMed ID: 803366
    [TBL] [Abstract][Full Text] [Related]  

  • 68. [Fatal hepatic necrosis due to a treatment course of rheumatoid arthritis with gold salts].
    Van Linthoudt D; Buss W; Beyner F; Ott H
    Schweiz Med Wochenschr; 1991 Jul; 121(30):1099-102. PubMed ID: 1678206
    [TBL] [Abstract][Full Text] [Related]  

  • 69. [Possible role of cellular immunity against tubular basement membrane antigen (TBM) in gold nephropathy in rheumatoid arthritis patients].
    Wakashin Y; Ueda S; Yoshida H; Mori T; Mori Y; Iesato K; Ogawa M; Wakashin M
    Nihon Jinzo Gakkai Shi; 1992 Jun; 34(6):657-67. PubMed ID: 1362229
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Combination therapy for rheumatoid arthritis: new paradigms of treatment.
    Wilke WS
    Cleve Clin J Med; 1993; 60(2):101-2. PubMed ID: 8095190
    [No Abstract]   [Full Text] [Related]  

  • 71. "Chorée fibrillaire de Morvan" followed by Guillain-Barré syndrome in a patient receiving gold therapy.
    Vernay D; Dubost JJ; Thevenet JP; Sauvezie B; Rampon S
    Arthritis Rheum; 1986 Nov; 29(11):1413-4. PubMed ID: 3778549
    [No Abstract]   [Full Text] [Related]  

  • 72. [Acute colitis during treatment with gold salts].
    Manigand G; Dumont D; Faux N; Taillandier J; Gaultier T; Fritsch J; Szekely AM
    Presse Med; 1983 Oct; 12(34):2112-3. PubMed ID: 6226039
    [No Abstract]   [Full Text] [Related]  

  • 73. Evidence that D-penicillamine alters the course of rheumatoid arthritis.
    Gibson T; Huskisson EC; Wojtulewski JA; Scott PJ; Balme HW; Burry HC; Grahame R; Hart FD
    Rheumatol Rehabil; 1976 Aug; 15(3):211-5. PubMed ID: 823633
    [No Abstract]   [Full Text] [Related]  

  • 74. The natural course of gold and penicillamine nephropathy: a longterm study of 54 patients.
    Hall CL
    Adv Exp Med Biol; 1989; 252():247-56. PubMed ID: 2782197
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Prolonged cholestasis and ductopenia following gold salt therapy.
    Basset C; Vadrot J; Denis J; Poupon J; Zafrani ES
    Liver Int; 2003 Apr; 23(2):89-93. PubMed ID: 12654130
    [TBL] [Abstract][Full Text] [Related]  

  • 76. [The potentials of a peroral gold preparation (Ridaura) in treating rheumatoid arthritis based on prospective observation data].
    Slobodina GA; Kanevskaia MZ; Krel' AA; Chichasova NV; Pokryshkin VI
    Ter Arkh; 1988; 60(12):80-4. PubMed ID: 3247662
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Action of sodium aurothiopropanol, chloroquine, D-penicillamine and levamisole on picryl chloride-delayed hypersensitivity in mice.
    Tarayre JP; Lauressergues H
    J Pharm Pharmacol; 1980 Aug; 32(8):584-6. PubMed ID: 6106701
    [No Abstract]   [Full Text] [Related]  

  • 78. Antiarthritic synergism of combined oral and parenteral chrysotherapy. I. Studies in adjuvant-induced arthritis in rats.
    Finkelstein AE; Ladizesky M; Borinsky R; Kohn E; Ginsburg I
    Inflammation; 1988 Aug; 12(4):373-82. PubMed ID: 3139562
    [TBL] [Abstract][Full Text] [Related]  

  • 79. A 10 year follow up of parenteral gold therapy in patients with rheumatoid arthritis.
    Bendix G; Bjelle A
    Ann Rheum Dis; 1996 Mar; 55(3):169-76. PubMed ID: 8712879
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Gold-induced aplastic pancytopenia: 14-month survival through multiple transfusions.
    Reychler R; De Geeter T; Verbruggen LA
    Clin Rheumatol; 1986 Jun; 5(2):275-7. PubMed ID: 3731724
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.